1.
Salmaan Keshavjee: tackling tuberculosis (without rocket science).
by Watts, Geoff
Lancet (London, England), December 5, 2015, Vol.386(10010), p.2247
2.
Modifying the determinants of α-ketoacid substrate selectivity in mycobacterium tuberculosis α-isopropylmalate synthase
by Hunter, Michael F.C
FEBS Letters, 02 May 2014, Vol.588(9), pp.1603-1607
3.
Concise synthesis of an arabinofuranose hexasaccharide present in the cell wall of Mycobacterium tuberculosis
by Reddy, Karnakar C
Tetrahedron Letters, 09 May 2012, Vol.53(19), pp.2461-2464
4.
Subacute Tuberculous Constrictive Pericarditis
by de Agustín, José
Journal of the American College of Cardiology, March 13, 2012, Vol.59(11), p.e21
5.
Cystic Tuberculous Pericarditis
by Lin, Ting-Wei
Journal of the American College of Cardiology, Oct 8, 2013, Vol.62(15), p.1393
6.
Amino-acid substitutions at the domain interface affect substrate and allosteric inhibitor binding in α-isopropylmalate synthase from Mycobacterium tuberculosis
by Huisman, Frances H.A
Biochemical and Biophysical Research Communications, 05 April 2013, Vol.433(2), pp.249-254
7.
Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques
by Lin, Philana Ling
Proceedings of the National Academy of Sciences of the United States of America, 28 August 2012, Vol.109(35), pp.14188-93
8.
An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity.
by Danilchanka, Olga
Proceedings of the National Academy of Sciences of the United States of America, May 6, 2014, Vol.111(18), pp.6750-6755
9.
A Pd-mediated new strategy to functionalized 2-aminochromenes: their in vitro evaluation as potential anti tuberculosis agents.
by Ram Reddy, T
Bioorganic & medicinal chemistry letters, November 1, 2011, Vol.21(21), pp.6433-6439
10.
A medicinal chemists’ guide to the unique difficulties of lead optimization for tuberculosis
by Dartois, Véronique
Bioorganic & Medicinal Chemistry Letters, 01 September 2013, Vol.23(17), pp.4741-4750
11.
Discovery of novel inhibitors targeting the Mycobacterium tuberculosis O-acetylserine sulfhydrylase (CysK1) using virtual high-throughput screening
by Jean Kumar, Variam Ullas
Bioorganic & Medicinal Chemistry Letters, 01 March 2013, Vol.23(5), pp.1182-1186
12.
Development of a three component complex to increase isoniazid efficacy against isoniazid resistant and nonresistant Mycobacterium tuberculosis
by Manning, Thomas
Bioorganic & Medicinal Chemistry Letters, Oct 15, 2015, Vol.25(20), p.4621(7)
13.
Reverse type I inhibitor of Mycobacteriumtuberculosis CYP125A1
by Ouellet, Hugues
Bioorganic & Medicinal Chemistry Letters, 01 January 2011, Vol.21(1), pp.332-337
14.
Inhibition of the β-carbonic anhydrases from Mycobacterium tuberculosis with C-cinnamoyl glycosides: Identification of the first inhibitor with anti-mycobacterial activity
by Buchieri, María V
Bioorganic & Medicinal Chemistry Letters, 01 February 2013, Vol.23(3), pp.740-743
15.
Inhibitory effect of oxygenated cholestan-3β-ol derivatives on the growth of Mycobacterium tuberculosis
by Schmidt, Arndt W
Bioorganic & Medicinal Chemistry Letters, 15 November 2013, Vol.23(22), pp.6111-6113
16.
Rational drug design based synthesis of novel arylquinolines as anti-tuberculosis agents
by Jain, Puneet P
Bioorganic & Medicinal Chemistry Letters, 15 November 2013, Vol.23(22), pp.6097-6105
17.
"I never gave up hope".(More news online)(Brief article)
by Sibbald, Barbara
CMAJ: Canadian Medical Association Journal, Feb 5, 2013, Vol.185(2), p.116(1)
18.
Spread of tuberculosis in a high school.
by Trollfors, Birger
Acta paediatrica (Oslo, Norway : 1992), March 2013, Vol.102(3), pp.e140-e141
19.
Innate Immunity to TB: A Druggable Balancing Act
by Lalvani, Ajit
Cell, Feb 3, 2012, Vol.148(3), pp.389-391
20.
Tuberculosis in pregnancy--a major maternal and perinatal challenge
by Jana, N
BJOG : an international journal of obstetrics and gynaecology, August 2011, Vol.118(9), pp.1145-6; author reply 1146
